Cystic fibrosis: Nutritional therapy against inflammation, oxidative stress, and infection;Mucoviscidose: Inflammation, stress oxydant, infection. Essais de manipulation nutritionnelle

Nutrition Clinique et Metabolisme

Volumn 14, Issue 3, 2000, Pages 201-205

  Munck, Anne ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

Author keywords

Anti oxydants; Cytokines; Free radicals; Polyunsaturated fatty acids

Indexed keywords

CYTOKINE; FREE RADICAL; LEUKOTRIENE; OMEGA 6 FATTY ACID; PROSTAGLANDIN;

CONFERENCE PAPER; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; INFECTION; INFLAMMATION; LUNG LAVAGE; NEWBORN PERIOD; NUTRITION; OXIDATIVE STRESS; PNEUMONIA; POLYMORPHONUCLEAR CELL; PROSTAGLANDIN SYNTHESIS; PSEUDOMONAS AERUGINOSA; RESPIRATORY FUNCTION; RESPIRATORY TRACT INFECTION;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 0033774950     PISSN: 09850562     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0985-0562(00)80023-0     Document Type: Conference Paper

References (18)

1. Cystic fibrosis lung inflammation: Early, sustained and severe
2. Early pulmonary inflammation in infants with cystic fibrosis
3. The relationship between infection and inflammation in the early stages of lung disease from CF
4. Cytokines in the lung in CF
5. Oxygen free radicals in CF: The concept of an oxydant -antioxydant imbalance
6. Role of free radicals in the pathogenesis of CF
7. Mitochondrial calcium uptake and oxygen consumption in CF
8. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells
9. High susceptibility for cystic fibrosis human airway gland cells to produce IL8 through IκB kinase a pathway in response to extracellular NaCl content
10. Treatment of pulmonary infective exacerbation of CF leads to improved anitoxydant status
11. Relation between essential fatty acid metabolism and gastrointestinal symptoms in CF
12. Effect of intraveinous fatty acid supplementation on nasal transepithelial potential difference in cystic fibrosis
13. Response to oral beta-carotene supplementation in patients with cystic fibrosis: A 16 month follow-up study
14. Impaired antioxidant status and increased lipid peroxydation in Cystic Fibrosis
15. Pathogenesis of pancreatic disease in cystic fibrosis